GB0312845D0 - Use of componds in medicine - Google Patents
Use of componds in medicineInfo
- Publication number
- GB0312845D0 GB0312845D0 GBGB0312845.1A GB0312845A GB0312845D0 GB 0312845 D0 GB0312845 D0 GB 0312845D0 GB 0312845 A GB0312845 A GB 0312845A GB 0312845 D0 GB0312845 D0 GB 0312845D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- componds
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0312845.1A GB0312845D0 (en) | 2003-06-04 | 2003-06-04 | Use of componds in medicine |
PCT/GB2004/002298 WO2004108119A2 (en) | 2003-06-04 | 2004-06-01 | Use of atp or derivatives in medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0312845.1A GB0312845D0 (en) | 2003-06-04 | 2003-06-04 | Use of componds in medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0312845D0 true GB0312845D0 (en) | 2003-07-09 |
Family
ID=9959316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0312845.1A Ceased GB0312845D0 (en) | 2003-06-04 | 2003-06-04 | Use of componds in medicine |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0312845D0 (en) |
WO (1) | WO2004108119A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20110576A1 (en) * | 2011-06-30 | 2012-12-31 | Medicam Health Science S R L | COMPOSITION INCLUDING THE ASSOCIATION OF MELISSA PHYTO-EXTRACT, METHYLAMIDE AND A SOURCE OF NUCLEOTIDES AND / OR NUCLEOSIDES AND ITS USE IN THE TREATMENT OF HEADACHE AND HEMICRYANES |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049372A (en) * | 1982-07-13 | 1991-09-17 | Eliezer Rapaport | Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels |
US6004945A (en) * | 1990-05-10 | 1999-12-21 | Fukunaga; Atsuo F. | Use of adenosine compounds to relieve pain |
US6462028B2 (en) * | 1997-07-25 | 2002-10-08 | Inspire Pharmaceuticals, Inc. | Method of promoting cervical and vaginal secretions |
WO2000023588A2 (en) * | 1998-10-16 | 2000-04-27 | Millennium Pharmaceuticals, Inc. | G-protein coupled receptors |
AU1252102A (en) * | 2000-11-07 | 2002-05-21 | Paradigm Therapeutics Ltd | Receptor |
US6946244B2 (en) * | 2001-08-07 | 2005-09-20 | Euroscreen, S.A. | Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13) |
EP1583543A4 (en) * | 2002-01-16 | 2009-09-09 | Eliezer Rapaport | Methods and therapeutic compositions in the treatment of advanced cancer |
-
2003
- 2003-06-04 GB GBGB0312845.1A patent/GB0312845D0/en not_active Ceased
-
2004
- 2004-06-01 WO PCT/GB2004/002298 patent/WO2004108119A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004108119A3 (en) | 2005-04-21 |
WO2004108119A2 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0307918D0 (en) | Therapeutic use | |
IL172316A0 (en) | Novel compounds and their use in therapy | |
IL176248A0 (en) | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof | |
GB0324761D0 (en) | Use of compounds in therapy | |
EP1682136A4 (en) | Therapeutic compounds and uses thereof | |
EP1633749A4 (en) | Deazaflavin compounds and methods of use thereof | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
GB0300805D0 (en) | Compounds and their use | |
GB0300804D0 (en) | Compounds and their use | |
AU2003215767A8 (en) | Devices for use in medicine | |
GB0312845D0 (en) | Use of componds in medicine | |
GB0312844D0 (en) | Use of compounds in medicine | |
GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use | |
GB0301143D0 (en) | Compounds and their use | |
GB0317133D0 (en) | Compounds and their use | |
GB0209874D0 (en) | Devices for use in medicine | |
GB0322990D0 (en) | Therapeutic use | |
GB0311457D0 (en) | New therapeutic use | |
GB0310251D0 (en) | Therapeutic methods and compositions for use therein | |
GB0326870D0 (en) | Therapeutic methods and compositions for use therein | |
GB0302801D0 (en) | Therapeutic methods and compositions for use therein | |
GB0303165D0 (en) | Therapeutic methods and compositions for use therein | |
GB0312822D0 (en) | Triazolo-pyrimidine compounds and their use in medicine | |
GB0301147D0 (en) | Compounds and their use | |
GB0311821D0 (en) | Compounds and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |